Liang, B., & Zhou, D. (2021). ROS-Activated homodimeric podophyllotoxin nanomedicine with self-accelerating drug release for efficient cancer eradication. Taylor & Francis Group.
Cita Chicago Style (17a ed.)Liang, Bingfeng, y Dangxia Zhou. ROS-Activated Homodimeric Podophyllotoxin Nanomedicine with Self-accelerating Drug Release for Efficient Cancer Eradication. Taylor & Francis Group, 2021.
Cita MLA (8a ed.)Liang, Bingfeng, y Dangxia Zhou. ROS-Activated Homodimeric Podophyllotoxin Nanomedicine with Self-accelerating Drug Release for Efficient Cancer Eradication. Taylor & Francis Group, 2021.
Precaución: Estas citas no son 100% exactas.